Spiller RC, Trotman IF, Higgins BE, Ghatei MA, Grimble GK, Lee YC, Bloom SR, Misiewicz JJ, Silk DB. The ileal brake—inhibition of jejunal motility after ileal fat perfusion in man. Gut 1984;25:365–374.
Spiller RC, Trotman IF, Adrian TE, Bloom SR, Misiewicz JJ, Silk DB. Further characterisation of the ‘ileal brake’ reflex in man—effect of ileal infusion of partial digests of fat, protein, and starch on jejunal motility and release of neurotensin, enteroglucagon, and peptide YY. Gut 1988;29:1042–1051.
Siegle ML, Schmid HR, Ehrlein HJ. Effects of ileal infusions of nutrients on motor patterns of canine small intestine. Am J Physiol 1990;259:G78-G85.
Pironi L, Stanghellini V; Miglioli M, Corinaldesi R, Giorgio RD, Ruggeri E, Tbsetti C, Poggioli G, Labate AMM, Monetti N, Gozzetti G, Barbara L, Go, VLW. Fat-induced ileal brake in humans: A dose-dependent phenomenon correlated to plasma levels of peptide YY. Gastroenterology 1993;105:733–739.
Pappas TN, Debas HT, Chang AM, Taylor IL. Peptide YY release by fatty acids is sufficient to inhibit gastric emptying in dogs. Gastroenterology 1986;91:1386–1389.
Read NW, McFarlane A, Kinsman RI, Bates TE, Blackball NW, Farrar GBJ, Hall JC, Moss G, Morris AP, O’Neill B, Welch I, Lee Y, Bloom SR. Effect of infusion of nutrient solutions into the ileum on gastrointestinal transit and plasma levels of neurotensin and enteroglucagon. Gastroenterology 1984;86:274–280.
Brown NJ, Richards WJ. Involvement of extrinsic innervation in the ‘ileal brake’ mechanism. J Gastrointest Motil 1991;3:175.
Read NW, Welch IMcL. Naloxone prevents the effect of ileal lipid on small bowel transit but not on gastric emptying. Gut 1984;25:A1326.
Brown NJ, Rumsey RDE, Bogentoft C, Read NW. The effect of adrenoceptor antagonist on the ileal brake mechanism in the rat. Br J Pharmacol 1992;105:751–755.
Brown NJ, Horton A, Rumsey RDE, Read NW. Granisetron and ondansetron: Effects on the ileal brake mechanism in the rat. J Pharm Pharmacol 1993;45:521–524.
Brown NJ, Rumsey RDE, Read NW. The effect of the cholecystokinin antagonist devazepide (L364718) on the ileal brake mechanism in the rat. J Pharm Pharmacol 1993;45:1033–1036.
Ohneda A, Nihei J, Kobayashi T, Umetz M, Sasaki T, Sanoyama K. Effect of insulin treatment upon response of extrapancreatic glucagon on arginine. Tohoku J Exp Med 1979; 129:207–217.
Wen J, Phillips SF, Sarr MG, Kost LJ, Holst JJ. PYY and GLP-1 contribute to feedback inhibition from the canine ileum and colon. Am J Physiol 1995;269:G945-G952.
Ohtani N, Sasaki I, Naito H, Shibata C, Funayama Y, Kamiyama Y, Takahashi M, Matsuno S. Inhibitory effect on peptide YY, neurotensin and glicentin on upper gastrointestinal motility in dogs. BiomedRes 1994;lS(Supplement 2):299–302.
Tbda M, Sasaki I, Naito H, Funayama Y, Kamiyama Y, Suzuki Y, Takahashi M, Matsuno S, Ohneda A, Igarashi H. Effect of ileo-jejunal transposition on intestinal structure and function in dogs. Biomed Res 1988;9(Supplement 3):1.57–162.
Sarr MG, Duenes JA. Early and long term effects of a model of intestinal autotransplantation on intestinal motor patterns. Surg Gynecol Obstet 1990;170:338–346.
Lin HC, Zhao XT, Wang LJ. Intestinal transit is more potently inhibited by fat in the distal (ileal brake) than in the proximal (jejunal brake) gut. Dig Dis Sci 1997;42:19–25.